Delving into the Latest Updates on Zhejiang Xinlifei Biotechnology Co., Ltd. with Synapse

Overview

Tags

Infectious Diseases

Urogenital Diseases

Live biotherapeutic products

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Live biotherapeutic products	1

Primary objective: To evaluate the safety and tolerability of XLF055 in the treatment of BV. Secondary objective: To evaluate the effectiveness of XLF055 in the treatment of BV. Exploratory objective: To explore the changes in microbial community characteristics, Lactobacillus, lactic acid and pH value in vaginal secretions of patients before and after medication.

Start Date03 Feb 2023

Sponsor / Collaborator

Zhejiang Xinlifei Biotechnology Co., Ltd.

CTR20212722

/ CompletedPhase 1

阴道用乳杆菌二联活菌胶囊单次给药对健康女性受试者的安全性、耐受性研究

[Translation] Study on the safety and tolerability of single-dose vaginal Lactobacillus dual-acti capsule in healthy female subjects

主要目的：评估阴道用乳杆菌二联活菌胶囊经阴道单次给药对健康女性的安全性、耐受性。探索性目的：初步观察阴道用乳杆菌二联活菌胶囊经阴道单次给药对健康女性阴道中乳杆菌的变化情况。

[Translation]

Main purpose: To evaluate the safety and tolerability of a single vaginal administration of a combination of Lactobacillus and Lactobacillus capsules in healthy women. Exploratory purpose: To preliminarily observe the changes in Lactobacillus in the vagina of healthy women after a single vaginal administration of a combination of Lactobacillus and Lactobacillus capsules.

Start Date08 Nov 2021

Sponsor / Collaborator

Zhejiang Xinlifei Biotechnology Co., Ltd.

100 Clinical Results associated with Zhejiang Xinlifei Biotechnology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Zhejiang Xinlifei Biotechnology Co., Ltd.

Login to view more data

100 Deals associated with Zhejiang Xinlifei Biotechnology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Zhejiang Xinlifei Biotechnology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2

1

Login to view more data